Plain-English translation of NCT06915545 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new medical device called the Aortic Arch Single Branch Covered Stent System, which is designed to repair a serious condition where the inner lining of the aorta (your body's main artery) tears in the aortic arch region. The stent graft is placed through blood vessels using a minimally invasive procedure, rather than open surgery. Researchers want to see if this new device is safe and effective for patients who need repair in this specific area and also need to protect an important artery called the left subclavian artery.
Standard treatments for aortic arch dissection can be challenging and carry significant risks. This trial exists to evaluate whether this newer branched stent graft approach offers a safer, more effective alternative that can treat the dissection while keeping blood flowing to the left subclavian artery at the same time.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would be admitted to the hospital to receive this minimally invasive procedure under general anesthesia. A catheter (thin tube) is threaded through your blood vessels to place the new stent graft in your aortic arch. After the procedure, you will have regular follow-up visits to monitor how well the device is working, including imaging tests and physical exams. The trial involves close medical supervision to ensure your safety and to gather data on how the treatment performs over time.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
China
Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Enrollment target
~135 participants
Started
April 2025
Primary completion
April 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
chang shu, Professor
Chinese Academy of Medical Sciences, Fuwai Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.